Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-09-25

Clinical Trial Update: Mesenchymal Stem Cells Co-transplantation in Alternative Donor Transplantation of Severe Aplastic Anemia. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating co-transplantation of mesenchymal stem cells in alternative donor transplantation for severe aplastic anemia; current status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesenchymal stem cells co-transplantation (mesenchymal stem cells)

Snippet

Sponsor: Guangzhou General Hospital of Guangzhou Military Command | Conditions: Severe Aplastic Anemia | Phase 2 | Status: UNKNOWN